Tumorigenic behaviour of c-Ha-ras oncogene transfected CaCo 2 cells is associated with increased proteolytic potency

Anticancer Research

Volumn 16, Issue 1, 1996, Pages 321-326

  De Vries, Johan E ^a   Van Driel, Marjolein ^a   Marxi, Patrick ^a   Van Der Linden, Edith P M ^a   De Bruin, Léon ^a   Moerkerk, Peter ^a   Verspaget, Hein W ^b   Bosman, Fred T ^c   Ten Kate, Joop ^d  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^d De Wever Hospital ^*  (Netherlands)

Author keywords

c Ha ras oncogene; CaCo 2; Colorectal carcinoma cell line; Differentiation; Gelatinase; Human; Plasminogen activator; Proliferative potential; Tumorigenicity

Indexed keywords

CHROMOGRANIN A; GELATIN; MUCIN; SUCRASE ISOMALTASE; UROKINASE;

ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; ONCOGENE C H RAS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

CACO-2 CELLS; CELL DIFFERENTIATION; CELL DIVISION; GELATINASES; GENES, RAS; HUMANS; PEPTIDE HYDROLASES; TRANSFECTION; URINARY PLASMINOGEN ACTIVATOR;

EID: 0030009432     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Cooper GM, ed: Oncogenes. first ed. Boston: Jones and Bartlett Publishers, 1990.
2. Parada LF, Tabin CJ, Shih C and Weinberg RA: Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature 297: 474-478, 1982
3. Goldfarb M, Shimizu K, Perucho M and Wigler M: Isolation and preliminary characterization of a human transforming gene from T24 bladder carcinoma cells. Nature 290: 404-409, 1982.
4. Pulciani S, Santos E, Lauver AV, Long LK, Robbins KC and Barbacid M: Oncogenes in human tumor cell lines: molecular cloning of a transforming gene from human bladder carcinoma cells. Proc Natl Acad Sci (USA) 79: 2845-2849, 1982.
5. Barbacid M: Ras genes. Annu Rev Biochem 56: 779-827, 1987.
6. Boguski MS and McCormick F: Proteins regulating ras and its relatives. Nature 366: 643-654, 1993.
7. Bourne HR, Sanders DA and McCormick F: The GTPase superfamily: conserved structure and molecular mechanism Nature 349: 117-127, 1991.
8. Vogel US, Dixon RA, Schaber MD, Diehl RE, Marshall MS, Scolnick EM, Sigal IS, and Gibbs JB: Cloning of bovine GAP and its interaction with oncogenic ras p21. Nature 335: 90-93, 1988.
9. Trahey M and McCormick F: A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. Science 238: 542-545, 1987.
10. Shimizu K, Birnbaum D, Ruley MA, Fasano O, Suard Y, Edlund L, Taparowsky E, Goldfarb M, and Wigler M: Structure of the Ki-ras gene of the human lung carcinoma cell line Calu-1. Nature 304: 497-500, 1983.
11. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61. 759-767, 1990.
12. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ, and Vogelstein B: Prevalence of ras gene mutations in human colorectal cancers. Nature 327: 293-297, 1987.
13. Forrester K, Almoguera C, Han K, Grizzle WE and Perucho M: Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 327: 298-303, 1987.
14. de Bruïne AP, de Vries JE, Dinjens WNM, Moerkerk PM, van der Linden EPM, Pijls M, ten Kate J, and Bosman FT: Human CaCo 2 cells transfected with c-Ha-ras as a model for endocrine differentiation in the large intestine. Differentiation. 53: 51-60, 1993.
15. Delage S, Chastre E, Empereur S, Wicek D, Veissiere D, Capeau J, Gespach C, and Cherqui G: Increased protein kinase C alpha expression in human colonic CaCo 2 cells after insertion of human Ha-ras or polyoma virus middle T oncogene. Cancer Res 53: 2762-2770, 1993.
16. Medema RH, de Vries-Smits AMM, van der Zon GCM, Maassen JA and Bos JL: Ras activation by insulin and epidermal growth factor through enhanced exchange of guanine nucleotides on p21ras. Mol Cell Biol 13. 155-162, 1993
17. Buday L and Downward J Epidermal growth factor regulates the exchange rate of guanine nucleotides on p21ras in fibroblasts. Mol Cell Biol 13: 1903-1910, 1993.
18. Riecken EO, Stallmach A, Zeitz M, Schulzke JD, Menge H and Gregor M: Growth and transformation of the small intestinal mucosa-importance of connective tissue, gut associated lymphoid tissue and gastrointestinal regulatory peptides. Gut 30: 1630-1640, 1989.
19. Quaroni A: Identification and biogenesis of intestinal cell-surface components. Progress in Cancer Research and Therapy 29: 267-293, 1984.
20. Thorgeirsson UP, Turpeenniemi-Hujanen T, Williams JE, Westin EH, Heilman CA, Talmadge JE, and Liotta LA: NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotypc in nude mice Mol Cell Biol 5: 259-262, 1985
21. Axelrod JH, Reich R and Miskin R: Expression of human recombinant plasminogen activators enhances invasion and experimental metastasis of H-ras-transformed NIH 3T3 cells Mol Cell Biol 9: 2133-2141, 1989.
22. Garbisa S, Pozzatti R, Muschel RJ, Saffiotti U, Ballin M, Goldfarb RH, Khoury G, and Liotta LA Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1 a. Cancer Res 47: 1523-1528, 1987
23. Hurlin PJ, Maher VM and McCormick JJ: Malignant transfer nation of human fibroblasts caused by expression of a transfected T24 HRAS oncogene. Proc Natl Acad Sci (USA) 86: 187-191, 1989
24. Bernhard EJ, Muschel RJ and Hughes EN: Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res 50 3872-3877, 1990.
25. Zweibaum A, Triadou N, Kedinger M, Augeron C, Robine-Leon S, Pinto M, Rousset and M, Haffen K: Sucrase-isomaltase: a marker of foetal and malignant epithelial cells of the human colon. Int J Cancer 32. 407-412, 1983.
26. Zweibaum A, Triadou N, Kedinger M et al: Sucrase-isomaltase: a marker of foetal and malignant epithelial cells of the human colon. Int J Cancer 32: 407-412, 1983.
27. Verstijnen CPHJ, Arends JW, Moerkerk PTM, Pijls M, Kuypers-Engelen B and Bosman FT: Colonic epithelium reactive monoclonal antibodies. Identification and immunohistochemical localization of the target epitopes. Histochemistry 92 397-406, 1989.
28. Lloyd RV and Wilson BS: Specific endocrine tissue marker defined by a monoclonal antibody. Sciencey 222: 628-630, 1983.
29. Schutte B, Reynders MM, van-Assche CL, Hupperets PS, Bosman FT and Blijham GH. An improved method for the immunocytochemical detection of bromodeoxyuridine-labeled nudei using flow cytometry. Cytometry 8. 372-376, 1987.
30. White RA, Terry N and Meistrich ML: New methods for calculating kinetic properties of cells in vitro using pulse labelling with bromodeoxyuridine. Cell Tissue Kinet 23: 561-573, 1990.
31. Binnema DJ, van Iersel JJL and Dooijewaard G: Quantitation of urokinase antigen in plasma and culture media by use of an ELISA. Thromb Res 43: 569-577, 1986.
32. Rijken DC, van Hinsbergh VWM and Sens EHC: Quantitation of tissue-type plasminogen activator in human endothelial cell cultures by use of an enzyme immunoassay Thromb Res 33: 145-153, 1984.
33. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
34. Zucker S, Wieman J, Lysik RM, Imhof B, Nagase H, Ramamurthy N, Liotta LA, and Golub LM: Gelatin-degrading type IV collagenase isolated from human small cell lung cancer. Invasion Metastasis 9: 167-181, 1989.
35. Hancock K and Tsang VCW: India ink staining of proteins on nitrocellulose paper Anal Biochem 133: 157-162, 1983.
36. Chang EH, Furth ME, Scolnick EM and Lowy DR: Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus. Nature 297: 479-483, 1982.
37. Beaulieu J-F and Quaroni A. Clonal analysis of sucrase-isomaltase expression in the human colon adenocarcinoma CaCo-2 cells. Biochem J 280. 599-608, 1991.
38. Fang XJ, Flowers M, Keating A, Cameron R and Sherman M: Ras transformation of simian virus 40-immortalized rat hepatocytes: an in vitro model of hepatocarcinogenesis. Cancer Res 52: 173-180, 1992.
39. Isom HC, Woodworth CD, Meng Y, Kreider J, Miller T and Mengel L: Introduction of the ras oncogene transforms a simian virus 40-immortalized hepatocyte cell line without loss of expression of albumin and other liver-specific genes. Cancer Res 52: 940-948, 1992.
40. Boukamp P, Stanbridge EJ, Foo DY, Cerutti PA and Fusenig NE: c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy. Cancer Res 50: 2840-2847, 1990.
41. Stacey DW and Kung H-F: Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein Nature 310. 508-511, 1984.
42. Feramisco JR, Gross M, Kamata T, Rosenberg M and Sweet RW: Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells Cell 38: 109-117, 1984.
43. Arends MJ, McGregor AH, Toft NJ, Brown EJH and Wyllie AH: Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability. Br J Cancer 68: 1127-1133, 1993.
44. Arends MJ, McGregor AH and Wyllie AH: Apoptosis is inversely related to necrosis and determines net growth in tumours bearing constitutively expressed myc, ras, and HPV oncogenes. Am J Pathol 144: 1045-1057, 1994.
45. Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Kronberger A, He CS, Bauer EA, and Goldberg GI: H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem 263: 6579-6587, 1988.
46. Bernhard EJ, Gruber SB and Muschel RJ: Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc Natl Acad Sci (USA) 91: 4293-4297, 1994.
47. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA and Goldberg GI: SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 264: 17213-17221, 1989.
48. Springman EB, Angleton EL, Birkedal-Hansen H and van Wart HE: Multiple modes of activation of latent human fibroblast collagenase: Evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc Natl Acad Sci (USA) 87: 364-368, 1990.
49. Sier CFM, Vloedgraven HJM, Ganesh S, Griffioen G, Quax PHA, Verheijen JH, Dooijewaard G, Welvaart K, van de Velde CJH, Lamers CBH, Verspaget HW: Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasis Gastroenterology 107. 1449-1456, 1994.
50. Testa JE, Medcalf RL, Cajot JF, Schleuning WD and Sordat B: Urokinase-type plasminogen activator biosynthesis is induced by the EJ-Ha-ras oncogene in CL26 mouse colon carcinoma cells. Int J Cancer 43: 816-822, 1989.
51. K Brunner G, Pohl J, Erkell LJ, Radler-Pohl A and Schirrmacher V: Induction of urokinase activity and malignant phenotype in bladder carcinoma cells after transfection of the activated Ha-ras oncogene. J Cancer Res Clin Oncol 115. 139-144, 1989.
52. Olson EN, Burgess R and Staudinger J: Protein kinase C as a transducer of nuclear signals. Cell Growth and Differentiation 4: 699-705, 1993.
53. L Sato Hr and Seiki M: Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumour cells. Oncogene 8. 395-405, 1993.